Cargando…

High Expression of TIMELESS Predicts Poor Prognosis: A Potential Therapeutic Target for Skin Cutaneous Melanoma

BACKGROUND: Skin cutaneous melanoma (SKCM) is the most lethal skin cancer with an increasing incidence worldwide. The poor prognosis of SKCM urgently requires us to discover prognostic biomarkers for accurate therapy. As a regulator of DNA replication, TIMELESS (TIM) has been found to be highly expr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Shixin, Wen, Shifeng, Liu, Hengdeng, Zhou, Ziheng, Liu, Yiling, Zhong, Jinbao, Xie, Julin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406824/
https://www.ncbi.nlm.nih.gov/pubmed/36034394
http://dx.doi.org/10.3389/fsurg.2022.917776
_version_ 1784774215627440128
author Zhao, Shixin
Wen, Shifeng
Liu, Hengdeng
Zhou, Ziheng
Liu, Yiling
Zhong, Jinbao
Xie, Julin
author_facet Zhao, Shixin
Wen, Shifeng
Liu, Hengdeng
Zhou, Ziheng
Liu, Yiling
Zhong, Jinbao
Xie, Julin
author_sort Zhao, Shixin
collection PubMed
description BACKGROUND: Skin cutaneous melanoma (SKCM) is the most lethal skin cancer with an increasing incidence worldwide. The poor prognosis of SKCM urgently requires us to discover prognostic biomarkers for accurate therapy. As a regulator of DNA replication, TIMELESS (TIM) has been found to be highly expressed in various malignancies but rarely reported in SKCM. The objective of this study was to evaluate the relationship between TIM and SKCM tumorigenesis and prognosis. METHODS: We obtained RNA sequencing data from TCGA and GTEx to analyze TIM expression and differentially expressed genes (DEGs). Subsequently, GO/KEGG, GSEA, immune cell infiltration analysis, and protein-protein interaction (PPI) network were used to perform the functional enrichment analysis of TIM-related DEGs. Moreover, the receiver operating characteristic (ROC) curves, Cox regression analysis, Kaplan–Meier (K-M) analysis, and nomograms were applied to figure out the clinical significance of TIM in SKCM. In addition, we investigated the relationship between TIM promoter methylation and SKCM prognosis through the UALCAN database. Finally, the immunohistochemical (IHC) results of normal skin and SKCM were analyzed to determine expression differences. RESULTS: TIM was significantly elevated in various malignancies, including SKCM, and high expression of TIM was associated with poor prognosis. Moreover, a total of 402 DEGs were identified between the two distinct TIM expression groups, and functional annotation showed enrichment with positive regulation of cell cycle and classic oncogenic pathways in the high TIM expression phenotype, while keratinization pathways were negatively regulated and enriched. Further analysis showed that TIM was correlated with infiltration of multiple immune cells. Finally, IHC validated the differential expression of TIM in SKCM. CONCLUSION: TIM might play a pivotal role in tumorigenesis of SKCM and is closely related to its prognosis.
format Online
Article
Text
id pubmed-9406824
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94068242022-08-26 High Expression of TIMELESS Predicts Poor Prognosis: A Potential Therapeutic Target for Skin Cutaneous Melanoma Zhao, Shixin Wen, Shifeng Liu, Hengdeng Zhou, Ziheng Liu, Yiling Zhong, Jinbao Xie, Julin Front Surg Surgery BACKGROUND: Skin cutaneous melanoma (SKCM) is the most lethal skin cancer with an increasing incidence worldwide. The poor prognosis of SKCM urgently requires us to discover prognostic biomarkers for accurate therapy. As a regulator of DNA replication, TIMELESS (TIM) has been found to be highly expressed in various malignancies but rarely reported in SKCM. The objective of this study was to evaluate the relationship between TIM and SKCM tumorigenesis and prognosis. METHODS: We obtained RNA sequencing data from TCGA and GTEx to analyze TIM expression and differentially expressed genes (DEGs). Subsequently, GO/KEGG, GSEA, immune cell infiltration analysis, and protein-protein interaction (PPI) network were used to perform the functional enrichment analysis of TIM-related DEGs. Moreover, the receiver operating characteristic (ROC) curves, Cox regression analysis, Kaplan–Meier (K-M) analysis, and nomograms were applied to figure out the clinical significance of TIM in SKCM. In addition, we investigated the relationship between TIM promoter methylation and SKCM prognosis through the UALCAN database. Finally, the immunohistochemical (IHC) results of normal skin and SKCM were analyzed to determine expression differences. RESULTS: TIM was significantly elevated in various malignancies, including SKCM, and high expression of TIM was associated with poor prognosis. Moreover, a total of 402 DEGs were identified between the two distinct TIM expression groups, and functional annotation showed enrichment with positive regulation of cell cycle and classic oncogenic pathways in the high TIM expression phenotype, while keratinization pathways were negatively regulated and enriched. Further analysis showed that TIM was correlated with infiltration of multiple immune cells. Finally, IHC validated the differential expression of TIM in SKCM. CONCLUSION: TIM might play a pivotal role in tumorigenesis of SKCM and is closely related to its prognosis. Frontiers Media S.A. 2022-05-19 /pmc/articles/PMC9406824/ /pubmed/36034394 http://dx.doi.org/10.3389/fsurg.2022.917776 Text en Copyright © 2022 Zhao, Wen, Liu, Zhou, Liu, Zhong and Xie. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Surgery
Zhao, Shixin
Wen, Shifeng
Liu, Hengdeng
Zhou, Ziheng
Liu, Yiling
Zhong, Jinbao
Xie, Julin
High Expression of TIMELESS Predicts Poor Prognosis: A Potential Therapeutic Target for Skin Cutaneous Melanoma
title High Expression of TIMELESS Predicts Poor Prognosis: A Potential Therapeutic Target for Skin Cutaneous Melanoma
title_full High Expression of TIMELESS Predicts Poor Prognosis: A Potential Therapeutic Target for Skin Cutaneous Melanoma
title_fullStr High Expression of TIMELESS Predicts Poor Prognosis: A Potential Therapeutic Target for Skin Cutaneous Melanoma
title_full_unstemmed High Expression of TIMELESS Predicts Poor Prognosis: A Potential Therapeutic Target for Skin Cutaneous Melanoma
title_short High Expression of TIMELESS Predicts Poor Prognosis: A Potential Therapeutic Target for Skin Cutaneous Melanoma
title_sort high expression of timeless predicts poor prognosis: a potential therapeutic target for skin cutaneous melanoma
topic Surgery
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406824/
https://www.ncbi.nlm.nih.gov/pubmed/36034394
http://dx.doi.org/10.3389/fsurg.2022.917776
work_keys_str_mv AT zhaoshixin highexpressionoftimelesspredictspoorprognosisapotentialtherapeutictargetforskincutaneousmelanoma
AT wenshifeng highexpressionoftimelesspredictspoorprognosisapotentialtherapeutictargetforskincutaneousmelanoma
AT liuhengdeng highexpressionoftimelesspredictspoorprognosisapotentialtherapeutictargetforskincutaneousmelanoma
AT zhouziheng highexpressionoftimelesspredictspoorprognosisapotentialtherapeutictargetforskincutaneousmelanoma
AT liuyiling highexpressionoftimelesspredictspoorprognosisapotentialtherapeutictargetforskincutaneousmelanoma
AT zhongjinbao highexpressionoftimelesspredictspoorprognosisapotentialtherapeutictargetforskincutaneousmelanoma
AT xiejulin highexpressionoftimelesspredictspoorprognosisapotentialtherapeutictargetforskincutaneousmelanoma